In previous papers (1-3) we showed that the Berkefeld filtrates of certain anaerobically produced autolysates of pneumococcus of Types I, II, or III cause in guinea pigs: (a) necrosis of the skin when injected intracutaneously; (b) hemorrhagic edema of the lungs and death when injected intratracheally; (c) pneumonia associated with unrestrained multiplication of the organism in the lung when injected intratracheally in sublethal doses combined with small amounts of living organisms; and cause in mice death with kidney lesions, when injected intravenously. We also demonstrated that immunization of horses with these autolysates stimulates the production of sera of marked antitoxic properties for the principles that cause, in guinea pigs necrosis of the skin and hemorrhagic edema of the lungs, and in mice kidney lesions and death (4, 5). Moreover, an antiautolysate serum, prepared by the immunization with the autolysate from one type of pneumococcus, neutralized the poisons affecting the skin and the lung produced from each of the other 3 types, demonstrating that these autolysate antitoxins and presumably the toxins are not type specific (1, 4, 5) .
the toxic autolysates are produced in vivo, that this work was undertaken.
If the autolysate toxin is produced in vivo during the growth of the organism in the tissues, one would expect that the autolysate antitoxin, through neutralization of the toxin, would at least delay death in animals injected with the pneumococcus. This, however, is not the case. We found that autolysate antitoxin injected even in large amounts is unable to protect or prolong the life of guinea pigs or mice injected intramuscularly or intraperitoneally with a lethal dose of pneumococcus. Moreover, Sabin (6) showed that our autolysate antitoxin, when used by itself or in combination with a so called subeffective dose of specific antibacterial serum, had no apparent effect on the progress of pneumococcus infection in mice injected intraperitoneally or in rabbits injected intracutaneously with large doses of virulent pneumococci. It seems, therefore, evident from our own work and from that of Sabin that toxic substances of the nature of those in the toxic autolysates neutralizable by the autolysate antitoxin, are not produced in the animal body during generalized infection with the pneumococcus.
However, there appears to be another way of looking at this problem. In pneumococcus pneumonia in man and in the guinea pig, pneumonia occurs with growth of the organisms in the lung, frequently without invasion of, or establishment of, the pneumococcus in other organs or tissues. Is it possible, then, that the poisons in the autolysates, especially the toxin that is injurious to the lungs, enabling pneumococci to grow in them, are produced in vivo only in the lung? If this is the case, the autolysate antitoxin, through neutralization of these poisons in the lung, might have a curative effect in pneumonia in delaying or arresting the spread of pneumococcus infection. Indirectly this neutralizing action in the lung might prevent the occurrence of a generalized infection, although it would have no direct effect on a pneumococcus sepsis once established. In an endeavor to answer this question we have produced pneumonia in guinea pigs and attempted to protect them with autolysate antitoxin.
Experimental Methods
Production of Pneumonia in Guinea Pigs.--Pneumonia was produced in guinea pigs by the three following methods. These pigs usually get moderately extensive pneumonia lasting about 2 days. In 2 instances a pig in this group died with an extensive pneumonia associated with unrestrained growth of pneumococci in the lung, similar to the pneumonia caused by the intratracheal injection of a mixture of small amounts of autolysate toxin and living pneumococci. All animals in this group died with a pneumococcus sepsis 2 to 5 days after injection.
2. Intratracheal injection of large amounts of living virulent pneumococci into guinea pigs prepared either immediately previously or 18 hours previously by intraperitoneal injection of small amounts of homologous antibacterial (horse) sera (7, 8) . (Pneumococci from 4 to 6 cc. of culture in 0.2 cc. to 0.25 cc. volume.) 1
These pigs usually develop extensive pneumonia and die 1 to 4 days after injection with sepsis. (The lung involvement is greater than that produced by method 1.) Occasionally the guinea pigs of this group develop extensive pneumonia associated with unrestrained growth of the organism in the lung. Very rarely an animal of this group survives.
3. Intratracheal injection of a small amount of living pneumococcus organisms combined with sublethal doses of staphylococcus toxin.
These pigs usually develop extensive pneumonia in 1 to 4 days after injection and sepsis. Frequently the pigs in this group develop extensive pneumonia associated with unrestrained growth of the organisms in the lung.
Pneumococcus Cultures Used.--A Pneumococcus Type I and a Pneumococcus Type II strain were used for inoculation of the guinea pigs in this work in all 3 groups of guinea pigs. Both strains were obtained from the blood of patients with lobar pneumonia at the Presbyterian Hospital. The virulence of the strains was kept up by passage through guinea pigs. The organisms were grown under vaseline seal on a double strength veal infusion broth containing 4 per cent Witte peptone. After 12 to 14 hours growth, the pneumococcus culture was iced and ~ntrifuged and the organisms taken up in the required amount of the supernatant broth. The pneumococcus suspension was then adjusted to a pH of 7 to 7.2 and kept in ice water during the experiment.
Staphylococcus Toxin.--The staphylococcus toxin used in this work was prepared from a hemolytic Staphylococcus aureus strain recovered from the blood of a case of staphylococcus septicemia in October, 1934. When injected intratracheally in guinea pigs in 0.1 cc. amounts, it produces hemorrhagic edema of the lungs and death.
Sera Used.--Pneumococcus autolysate antitoxin: The autolysate antitoxin used in these experiments was a concentrated and refined serum obtained from horses immunized ~ to the sterile toxic autolysate filtrates from Pneumococcus Types I, II, and III. This antitoxin contains no specific antibacterial substances for x In this work we shall speak of these partly immune guinea pigs as sensitized. 
Effect of Pneumococcus Autolysate Antitoxin on the Pneumonia Caused by the Intratracheal Injection of Large Amounts of Pneumococcus
In Table I is presented a protocol of an experiment in which autolysate antitoxin or normal horse serum was given intraperitoneally immediately after the intratracheal inoculation of pneumococcus suspension, and demonstrates clearly the protective effect of the antitoxin. There is a discrepancy in this experiment in that guinea pig 10 that received antitoxin died in 1 day. In a large number of animals inoculated intratracheally with large amounts of living pneumococci, we have found that there is a small percentage of guinea pigs (approximately 10 per cent) that appear to be especially susceptible to the organisms and we believe that a much greater susceptibility than normal explains the early death of this guinea pig. An instance of this in another experiment was the death of a guinea pig in 2 hours after the intratracheal inoculation of pneumococcus. This guinea pig showed at autopsy lungs already large, with patchy hemorrhagic pneumonia throughout. 4 guinea pigs inoculated with the same quantity of organisms as this latter guinea pig survived for 2 or 3 days. In respect to guinea pig 10, Table I , it is of interest to note that the culture from its heart blood was negative, whereas in all the 8 control guinea pigs, positive heart blood cultures were obtained. This occurred in another experiment in which 1 of 9 guinea pigs inoculated with antitoxin died and it had a negative heart culture at autopsy, while all the controls died having positive heart cultures.
Several experiments similar to the experiment, Table I , with minor variations have been carried out, always with substantially the same results. We found that one-half the amount of antitoxin injected in the experiment, Pneumococcus I Suspension.--The organisms from 3 cc. of culture were inoculated into each guinea pig. The normal horse serum or antitoxin was inoculated intraperitoneally into each pig immediately after the intratracheal inoculation of organisms. One animal from each group (no serum, horse serum, antitoxin) was inoculated, then a second animal from each group and so forth, so that any change that might possibly occur in the suspension of pneumococci during the time taken to inoculate would be distributed equally among the 3 groups of guinea pigs. This procedure was carried out in all our other experiments. * In the lung culture column, ± indicates less than 8 colonies on plate.
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Effect of Autolysate Antitoxin on the Pneumonia Caused in Specifically Sensitized Guinea Pigs by the Intratracheal Inoculation of Large Doses of Living Pneumococci
In Table II is presented a protocol of an experiment in which autolysate antitoxin or normal horse serum was given intraperitoneally 1 day and 2 hours before the intratracheal inoculation of pneumococci into sensitized guinea pigs. It is seen that only one of the 6 control guinea pigs survived whereas all the antitoxin treated guinea pigs survived, demonstrating the efficacy of the antitoxin against the pneumonia under the conditions of this experiment.
This type of experiment (Table II) has been repeated several times with variations as to the time at which the antitoxin and specific antibacterial serum were given in respect to the intratracheal inoculation of organisms, always with essentially the same results. In one experiment the autolysate antitoxin was given intravenously 18 hours after the injection of pneumococcus into sensitized guinea pigs at a time when the guinea pigs had symptoms of well advanced pneumonia, and the antitoxin treated guinea pigs lived much longer than the control pigs, or survived.
These experiments, therefore, indicate that the autolysate antitoxin in most instances saves guinea pigs from an almost surely fatal pneumonia caused by the injection of large doses of pneumococcus into specifically sensitized guinea pigs.
Effect of Autolysate Antitoxin on the Pneumonia Caused by the Intratracheal Injection of Mixtures of Staphflococcus Toxin and Pneumococcus Culture
Although, as has been pointed out previously, pneumococcus autolysate antitoxin has no effect on the progress of a systemic infection with the pneumococcus, from the foregoing experiments it is evident that the injection of autolysate antitoxin saved the great majority of guinea pigs from an almost surely fatal pneumonia. This would seem to favor the conjecture that the toxin or toxins in pneumococcus pneumonia are elaborated in the lung. But there appears to be another possible explanation of these results. The suspension of pneumococci injected to produce pneumonia contained per cubic centimeter approximately only 1/30 of the organisms present in the suspension from which the autolysate toxin was produced. However, it seems conceivable that in the lung and bronchi enough of the introduced pneumococci could have been autolyzed so as to produce sufficient toxin to cause a primary injury, thus enabling the pneumococci to become established in the lung.
If this were the case, the beneficial effect of the autolysate antitoxin could be ascribed to the neutralization of the poison or poisons assumed to have been produced from the in vivo autolysis of the inoculated pneumococci rather than to the neutralization of the poisons produced during the growth and autolysis of the freshly growing pneumococci in the lung. In such case the antitoxin might have prevented the start of the infection and saved the animal. From this reasoning, therefore, it appears that the foregoing experiments furnish no proof of the production of the autolysate poison in vivo from organisms growing in the lung.
We have already shown that autolysate antitoxin prevents the development of pneumonia and death otherwise induced by the intratracheal injection of small doses of living pneumococci combined with sublethal doses of pneumococcus autolysate poison (5) . But here again the beneficial effect of the antitoxin might be ascribed to the neutralization of the inoculated toxin and not to the neutralization of the autolysate toxin possibly elaborated in the lung by the growth of the organisms there.
It seemed to us that one way of answering this question was to infect animals intratracheally with doses of pneumococci too small to cause pneumonia by themselves, combined with a substance toxic for the lung but nonspecific for the pneumococcus, for the purpose of enabling the organisms to become established in the lung and thus cause pneumonia. If antitoxin were found effective in this kind of pneumonia, it would be logical to infer that the antitoxin had neutralized poisons produced in some way by the growing and autolyzing organisms and that therefore the autolysate poison or poisons are presumably produced in the lung. With this idea in mind, we produced pneumonia in guinea pigs by injecting them intratracheally with sublethal doses of staphylococcus toxin, which is toxic for lungs The pneumococcus antitoxin, diluted 1-2, was injected intraperitoneally 4 hours before the intratracheal inoculation. 0.3 cc. of Pneumococcus Type I (14 hours growth) was mixed with 0.1 cc. of staphylococcus toxin and 0.2 cc. of the mixture inoculated intratracheally into each guinea pig.
when injected intratracheally, mixed with small doses of living pneumococci and were able to save most of these animals with injections of autolysate antitoxin previously administered. Table III gives the results of one of the experiments of this kind.
This experiment which has been repeated several times always with substantially the same results demonstrates that pneumococcus autolysate antitoxin has a definitely beneficial effect on the pneumonia caused by the injection of mixtures of staphylococcus toxin and the pneumococcus. Regarding further control experiments, which are not included in the tables, it has been found: (a) that the pneumococcus antitoxin has no more detoxifying effect on the staphylococcus toxin (when mixed in vitro and inoculated into guinea pigs) than has normal horse serum, and that, therefore, the results of the above experiments are not caused by a nonspecific neutralization or destruction of the staphylococcus toxin; and (b) that normal horse serum given intraperitoneally has no effect in prolonging the life or saving the guinea pigs inoculated with pneumococcus culture + staphylococcus toxin mixtures.
These experiments with staphylococcus toxin show clearly that the antitoxin neutralizes the poison or poisons produced in the lung by the invading and growing organism and that presumably these poisons are the same as those present in the toxic autolysate.
DISCUSSION
The experiments in this paper demonstrate that pneumococcus autolysate antitoxin under certain conditions is efficacious against pneurnococcus pneumonia in guinea pigs. The plausible explanation of these results is that the antitoxin neutralizes poisons manufactured by the growing and autolyzing pneumococci in the lung, thus preventing the spread of the infection by preventing damage to the tissues. Since the antitoxin is produced by the immunization of horses with the toxic autolysates and since it neutralizes in vitro all the so far determined poisons contained in the autolysates, and in vivo the toxin that enables pneumococci to grow in the lung, 3 it is reasonable to believe that the poisons neutralized by the antitoxin in the lung are similar to those present in the toxic autolysates.
Whether all the toxic effects of the autolysates are important in the production of pneumonia is impossible to say. The toxins that enable pneumococci to grow in the lung would appear to be the most important toxins in this respect. That the dermotoxic substance in the autolysates has little if any importance in pneumococcus infec-tions appears probable from the work of Sabin. He showed that the autolysate antitoxin had no beneficial effect against the Goodner (9) so called intradermal pneumonia in rabbits caused by the intradermal infection by virulent pneumococci. Even large doses of autolysate antitoxin did not appear to delay or arrest the development of the local lesion nor to modify the fully developed lesion.
If it is confirmed that the pneumococcus autolysate toxin is produced only in the lung in pneumonia, it would seem that in pneumococcus infections one must distinguish between poisons that are produced in the lung and those that are produced when the organism is growing in other tissues generally. The dermotoxic and fever producing toxins of Coca (10) may possibly belong in the latter class of poisons. CONCLUSIONS 1. In rabbits, guinea pigs, and mice pneumococcus autolysate antitoxin has no effect against generalized infection by the pneumococcus.
2. In a large proportion of cases of pneumonia and sepsis caused by the intratracheal inoculation of large amounts of living pneumococci in normal or sensitized guinea pigs, autolysate antitoxin saves the animal.
3. The autolysate antitoxin is protective in most cases of pneumonia and sepsis caused by the intratracheal inoculation of small amounts of living pneumococci combined with sublethal doses of staphylococcus toxin.
4. These experiments indicate that in pneumococcus pneumonia of guinea pigs the autolysate toxin or toxins are elaborated only in the lungs.
